ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2660

Do Ultrasonographic Lesions of Salivary Glands Evolve in SjöGren Patients during Follow-up ?

Alain Saraux1, Valerie Devauchelle2, Sandrine Jousse-Joulin3, Divi Cornec4, Pierre Gazeau5 and Dewi Guellec5, 1Rheumatology Department, CHU de la Cavale Blanche, Brest Cedex, France, 2Service de Rhumatologie, Department of Rheumatology, Brest University Hospital, Brest, France, Brest, France, 3Rheumatology, CHu La cavle Blanche, Brest, France, 4Department of rheumatology, Brest Occidentale University, Brest, France, 5Rheumatology, CHU Brest, Brest, France

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Salivary gland, Sjogren's syndrome, time management and ultrasonography

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 15, 2016

Title: Sjögren's Syndrome - Poster II: Clinical Science

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: to evaluate if the salivary glands ultrasonographic score (SGUS) is modified during follow-up in primitive Sjögren patients (pSS) and to compare pSS with idiopathic sicca syndromes (non-pSS).

Methods: this study was performed in the Brittany cohort of patients with suspected pSS. All patients had standardized clinical, biological and imaging evaluation. pSS diagnosis was considered according to the AECG criteria. Patients with or without pSS had ultrasonography of both parotid glands and both submandibular glands; they were graded on a 5-point scale (0 to 4). During follow-up, a second ultrasonography was performed. Patients treated with Rituximab were excluded. Salivary-gland ultrasonography was performed by local expert who was unaware of the final diagnosis. We compared the ultrasonographic score between pSS and non-pSS at inclusion and at second evaluation for the sum of the score of the four glands and the maximum score among the four glands.

Results: of the 49 included patients, 29 received a diagnosis of pSS. At baseline, pSS and non-pSS were similar concerning demographics, Schirmer test and salivary flow. Biopsy positivity and SGUS were statistically different at inclusion between pSS and non-pSS (p<0.001). Sum of the scores of the four glands and maximum score among the four glands was respectively of 8.9 and 2.7 for pSS and 2.1 and 0.8 in non-pSS. Percentage of patients with at least one score > 2 was respectively of 75.8 % and 25.0 % in pSS and non-pSS. During follow-up, a second ultrasonography of salivary glands was performed with a mean delay of 1.9 (+/-1.6) years. There was no difference between sum of the score of the four glands and maximum score among the four glands at second ultrasonography examination between pSS and non-pSS. Significant difference between sum of the scores of the four salivary glands and maximum score among the four glands of pSS and non-pSS was still present at second salivary glands ultrasonography with (p<0.001). No difference was found when parotids and submandibular glands were analyzed apart.

Conclusion: with a mean delay of two years, SGUS is not modified, even in patients with pSS. This observation is also effective in parotid and submandibular glands when taken apart.


Disclosure: A. Saraux, None; V. Devauchelle, None; S. Jousse-Joulin, None; D. Cornec, None; P. Gazeau, None; D. Guellec, None.

To cite this abstract in AMA style:

Saraux A, Devauchelle V, Jousse-Joulin S, Cornec D, Gazeau P, Guellec D. Do Ultrasonographic Lesions of Salivary Glands Evolve in SjöGren Patients during Follow-up ? [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/do-ultrasonographic-lesions-of-salivary-glands-evolve-in-sjogren-patients-during-follow-up/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/do-ultrasonographic-lesions-of-salivary-glands-evolve-in-sjogren-patients-during-follow-up/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology